BEAM · Beam Therapeutics Inc.
$26.75
+0.24 (+0.91%)
At close · Aug 14
Market Cap
$2.76B
Shares
103.29M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding BEAM
249 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| ARK Innovation ETF | — | 6,538,304 | $198,306,760 | 3.06% | Long | 2026-04-30 | |
| Fidelity Growth Company Fund | — | 3,461,620 | $113,991,147 | 0.12% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 3,248,626 | $77,414,758 | 1.04% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 3,097,050 | $73,802,702 | 0.00% | Long | 2026-03-31 | |
| ARK Genomic Revolution ETF | — | 2,212,153 | $67,094,600 | 5.43% | Long | 2026-04-30 | |
| iShares Russell 2000 ETF | — | 2,338,510 | $55,726,693 | 0.08% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,233,453 | $53,223,185 | 0.03% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 980,134 | $32,275,813 | 0.12% | Long | 2026-05-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 1,248,869 | $29,760,548 | 0.08% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 945,820 | $28,686,721 | 0.09% | Long | 2026-04-30 | |
| Fidelity Series Growth Company Fund | — | 820,099 | $27,005,860 | 0.11% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,100,832 | $26,232,827 | 0.03% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,093,992 | $26,069,829 | 0.24% | Long | 2026-03-31 | |
| iShares Russell 2000 Growth ETF | — | 776,898 | $18,513,479 | 0.15% | Long | 2026-03-31 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 758,540 | $18,076,008 | 0.22% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 510,808 | $16,820,907 | 0.04% | Long | 2026-05-31 | |
| iShares Biotechnology ETF | — | 692,124 | $16,493,315 | 0.20% | Long | 2026-03-31 | |
| Select Pharmaceuticals Portfolio | — | 500,600 | $16,484,758 | 1.10% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 491,128 | $16,172,845 | 0.09% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 476,273 | $15,683,670 | 0.07% | Long | 2026-05-31 | |
| ARK Venture Fund | — | 476,097 | $14,440,022 | 1.67% | Long | 2026-04-30 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 426,898 | $14,057,751 | 0.01% | Long | 2026-05-31 | |
| U.S. SMALL CAP PORTFOLIO | — | 444,512 | $13,482,049 | 0.07% | Long | 2026-04-30 | |
| Fidelity Capital Appreciation Fund | — | 363,700 | $11,031,021 | 0.14% | Long | 2026-04-30 | |
| U.S. MICRO CAP PORTFOLIO | — | 325,735 | $9,879,543 | 0.13% | Long | 2026-04-30 | |
| Dimensional U.S. Small Cap ETF | — | 320,746 | $9,728,226 | 0.07% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 274,310 | $9,033,028 | 0.05% | Long | 2026-05-31 | |
| Select Biotechnology Portfolio | — | 244,914 | $8,065,018 | 0.15% | Long | 2026-05-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 239,418 | $7,261,548 | 0.02% | Long | 2026-04-30 | |
| U.S. CORE EQUITY 2 PORTFOLIO | — | 215,675 | $6,541,423 | 0.02% | Long | 2026-04-30 | |
| Schwab Small-Cap Index Fund | — | 209,702 | $6,360,262 | 0.09% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 184,503 | $6,075,684 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXPLORER FUND | — | 196,215 | $5,951,201 | 0.03% | Long | 2026-04-30 | |
| Direxion Daily S&P Biotech Bull 3X Shares | — | 186,154 | $5,646,051 | 1.09% | Long | 2026-04-30 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 168,010 | $5,532,569 | 0.09% | Long | 2026-05-29 | |
| Avantis U.S. Small Cap Equity ETF | — | 166,860 | $5,494,700 | 0.20% | Long | 2026-05-31 | |
| American Beacon ARK Transformational Innovation Fund | — | 154,900 | $5,316,168 | 3.32% | Long | 2026-06-30 | |
| Fidelity Series Total Market Index Fund | — | 152,206 | $5,012,144 | 0.00% | Long | 2026-05-31 | |
| Invesco RAFI US 1500 Small-Mid ETF | — | 159,037 | $4,823,592 | 0.17% | Long | 2026-04-30 | |
| Large-Cap Growth Portfolio | — | 129,052 | $4,429,065 | 0.31% | Long | 2026-06-30 | |
| Master Small Cap Index Series | — | 155,367 | $3,702,396 | 0.08% | Long | 2026-03-31 | |
| Nuveen Small Cap Blend Index Fund | — | 114,905 | $3,485,069 | 0.09% | Long | 2026-04-30 | |
| U.S. CORE EQUITY 1 PORTFOLIO | — | 112,091 | $3,399,720 | 0.01% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 131,892 | $3,142,986 | 0.00% | Long | 2026-03-31 | |
| Nuveen Equity Index Fund | — | 103,476 | $3,138,427 | 0.01% | Long | 2026-04-30 | |
| BlackRock Advantage Small Cap Core Fund | — | 91,226 | $3,004,072 | 0.06% | Long | 2026-05-29 | |
| First Trust Small Cap Growth AlphaDEX Fund | — | 98,006 | $2,972,522 | 0.28% | Long | 2026-04-30 | |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND | — | 89,596 | $2,950,396 | 0.18% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | — | 122,904 | $2,928,802 | 0.12% | Long | 2026-03-31 | |
| LVIP State Street Small-Cap Index Fund | — | 70,000 | $2,402,400 | 0.11% | Long | 2026-06-30 |
Showing 1–50 of 249 positions
Key facts
CIK
1745999
CUSIP
07373V105
13F (30d)
269 filings
261 filers
Visit website
Investor relations